Inflammatory mediators like Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-alpha) activate STAT3 and NF-κB signaling pathways to promote cancer cell proliferation (33, 34). Here, STAT3 is linked to cancer.